Medicine is not one thing. It is a field of devoted clinicians, public-health successes, corporate vendors, regulators, insurers, universities, patients, and states. The question of capture begins where this complexity is flattened into a command chain that treats care, funding, licensing, and consent as its own property.
The documented case is already strong. American medical education was professionalized through standards that improved laboratory training while also closing many schools and deepening racial exclusion. Drug regulation is funded in part through industry user-fee systems. Pharmaceutical companies have repeatedly paid major criminal and civil penalties for fraud. Public institutions have committed grave nonconsensual abuses. No total theory is required before those facts demand institutional humility, transparency, independent replication, and a patient’s living right to question.
The Flexner Settlement
The 1910 Flexner Report transformed U.S. medical education. It raised expectations for laboratory science, clinical instruction, facilities, and admissions standards. The result was not simply a coup by industry, nor was it an unmixed triumph. Many weak and exploitative schools closed; medical training became more standardized. At the same time, the reform was funded and implemented through elite philanthropic power that favored a narrow institutional model and failed Black medical education catastrophically.
Carnegie funded the report. Rockefeller’s General Education Board helped finance the restructuring. Of the historically Black medical schools then operating, only Howard and Meharry remained after the Flexner era. Recent historical research documents how philanthropic support was radically unequal: the General Education Board gave vastly more to White institutions while new standards became impossible for underfunded Black schools to meet.
That is the structural lesson. Standardization can improve quality and still become an instrument of exclusion. A system is not absolved by the fact that one of its outcomes is good; it must also answer for who was denied the means to meet its standard and who was allowed to define the standard in the first place.
Incentive Is Not a Conspiracy Theory
Pharmaceutical research has produced therapies that save lives. It is also a profit-driven industry with a long, documented record of distorted evidence, deceptive marketing, and regulatory failure. The opioid crisis is the clearest modern proof that revenue can override care at population scale. Purdue Pharma’s conduct was not an abstract concern about incentives; it became the subject of litigation, criminal proceedings, and a vast public-health catastrophe.
GlaxoSmithKline and Pfizer have paid multibillion-dollar penalties for unlawful promotion and related misconduct. These cases do not prove that every product from a pharmaceutical company is harmful. They prove that institutional trust cannot rest on branding, credentials, or the presumption that regulated firms have no motive to mislead.
The same applies to the state. Tuskegee and the Guatemala syphilis experiments are admitted records of medicine severed from consent. They establish a permanent rule: official status does not convert a violation into care.
Regulation, Liability, and the Boundary
FDA drug-review programs receive Congressionally authorized user fees from regulated companies. These funds go to the Treasury and are restricted by statute, not paid to individual reviewers; the arrangement does not prove a bought decision. It does create an enduring institutional tension: the agency responsible for independence depends in part on fees and performance agreements negotiated with the industry it regulates.
The National Childhood Vaccine Injury Act created the Vaccine Injury Compensation Program, a no-fault alternative to ordinary litigation for covered vaccines. It was designed to preserve supply, stabilize costs, and compensate certain injuries. It does not create absolute immunity: petitioners must generally proceed through the program first, and some paths to subsequent litigation remain. But the arrangement is still exceptional. When a state encourages or requires a medical product, limits the ordinary tort path, and asks the recipient to absorb residual uncertainty, accountability must become more—not less—visible.
This is where Boundary Sovereignty applies. Consent is not a public-relations flourish after the clinical decision. It is part of the clinical reality. A patient is not raw material for a population objective. Public goods matter; so do the body, judgment, and moral agency of the person through whom those goods are pursued.
What the Record Does—and Does Not—Establish
The historical record establishes institutional concentration, conflicts of interest, criminal misconduct, past medical abuse, safety failures, and legal structures that can distance makers and decision-makers from individual harms. It justifies suspicion of unaccountable power and a demand for open data, independent oversight, honest risk communication, and genuine refusal.
It does not establish that all pharmaceuticals are poison, that all vaccines are harmful, that infectious disease is unreal, or that every physician participates in an intentional extraction program. Those claims erase distinctions that patients need in order to make real decisions.
The more direct conclusion is harder and more useful: no institution owns the body it claims to serve. Medicine remains medicine only when it can tell the truth about its limits, repair its harms, and meet a sovereign person rather than an administrable unit.
Sources
Carnegie and Rockefeller’s Philanthropic Legacy: Exclusion of African Americans From Medicine. Academic Medicine (2023). https://pubmed.ncbi.nlm.nih.gov/36512812/
FDA. “FDA: User Fees Explained.” https://www.fda.gov/industry/fda-user-fee-programs/fda-user-fees-explained
HRSA. “About the National Vaccine Injury Compensation Program.” https://www.hrsa.gov/vaccine-compensation/about
HRSA. “Frequently Asked Questions: National Vaccine Injury Compensation Program.” https://www.hrsa.gov/vaccine-compensation/faq
Geison, Gerald L. The Private Science of Louis Pasteur. Princeton University Press, 1995.
National Academies of Sciences, Engineering, and Medicine. The Flexner Report’s Impact on African American Medical Education. 2022. https://www.ncbi.nlm.nih.gov/books/NBK579979/
U.S. Department of Justice. “Justice Department Announces Largest Health Care Fraud Settlement in Its History.” 2012. https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history